Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy
Information source: Shaheed Beheshti Medical University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Proliferative Vitreoretinopathy
Intervention: Triamcinolone acetonide (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: Shaheed Beheshti Medical University Official(s) and/or principal investigator(s):
Hamid Ahmadieh, MD, Principal Investigator, Affiliation: Ophthalmic Research Center of Shaheed Beheshti Medical University
Summary
To evaluate the effect of triamcinolone acetonide in silicone-filled eyes on the outcome of
surgery for PVR.
Clinical Details
Study design: Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Efficacy Study
Primary outcome: Single-operation retinal reattachment rate sixmonths after surgery.
Secondary outcome: Visual acuityRetinal reproliferation Intraocular pressure Early silicone oil emulsification
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Cases of rhegmatogenous retinal detachment complicated by PVR grade C undergoing
vitrectomy and silicone oil tamponade.
Exclusion Criteria:
- History of trauma
- Presence of diabetic retinopathy
- History of vein occlusion
- Giant retinal tear
Locations and Contacts
Hamid Ahmadieh,MD, Tehran 16666, Iran, Islamic Republic of
Additional Information
Starting date: June 2001
Ending date: June 2003
Last updated: October 11, 2006
|
